Related Experiment Video
Updated: May 8, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Double-blind food challenges in children in general paediatric practice: useful and safe, but not without pitfalls
1Princess Amalia Children's Clinic, Isala klinieken, PO Box 10400, 8000 GK Zwolle, The Netherlands.
Insights
Double-blind placebo-controlled food challenges (DBPCFC) are safe for diagnosing food allergies in children. Most children tested negative for allergies to cow's milk, egg, soy, and hazelnut, but not peanut.
Area of Science:
- Allergy and Immunology
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Food allergies are a growing concern in pediatric populations.
- Accurate diagnosis is crucial for effective management and prevention of allergic reactions.
- Double-blind placebo-controlled food challenges (DBPCFC) are the gold standard for diagnosing food allergies.
Purpose of the Study:
- To evaluate the safety and efficacy of DBPCFC for common food allergens in a general pediatric setting.
- To describe the outcomes of DBPCFC in children aged 0-18 years.
- To identify factors associated with positive DBPCFC results and potential challenges in interpretation.
Main Methods:
- Conducted DBPCFC for cow's milk, hen's egg, soy, peanut, and hazelnut between 2006 and 2011.
- Utilized a standardized, double-blind protocol over two hospital admissions with a one-week interval.
- Included children aged 0-18 years undergoing diagnostic food challenges.
Main Results:
- 234 DBPCFC were performed in 209 children; most challenges were negative (e.g., cow's milk 57.5%, peanut 40.0%, egg 66.7%).
- Serious allergic reactions (wheeze, anaphylaxis) were rare (0.9%).
- Non-specific symptoms complicated interpretation, leading to potential false-positive results in 22.4% of physician-reported positive tests.
Conclusions:
- DBPCFC can be safely implemented in general hospitals for diagnosing various food allergies in children.
- The majority of tested children showed negative results, except for peanut allergy.
- Careful interpretation is needed to avoid misdiagnosis due to non-specific symptoms.
Objective:
To describe results of double-blind placebo-controlled food challenges (DBPCFC) with cow's milk, hen's egg, soy, peanut and hazelnut in general paediatric practice.
Methods:
Food challenges were performed between January 2006 and June 2011, in children 0-18 years of age, on two half-day hospital admissions with a one-week interval. Tests were performed in a double-blind fashion following a standardised protocol with validated recipes.
Results:
Overall, 234 food challenges were performed in 209 children: 160 with cow's milk, 35 with peanut, 21 with hen's egg, 11 with hazelnuts, and 7 with soy. In two thirds of the cases, the DBPCFC was negative (cow's milk: 57.5%; peanut: 40.0%; hen's egg: 66.7%, hazelnut: 90.9%, soy: 100%). The only patient characteristic significantly associated with a positive DBPCFC was the presence of symptoms from three different organ systems (p=0.007). Serious systemic allergic reactions with wheeze or anaphylaxis occurred in only two children (0.9%). Symptoms were recorded on 29.3% of placebo days. In 30/137 children with a negative test (22%), symptoms returned when reintroducing the allergen into the diet, mostly (66.7%) transient. Of the 85 tests regarded as positive by the attending physician, 19 (22.4%) did not meet predefined criteria for a positive test. This was particularly common with non-specific symptoms.
Conclusion:
A DBPCFC can be safely performed in a general hospital for a range of food allergens. The test result is negative in most cases except for peanut. Non-specific symptoms may hamper the interpretation of the DBPCFC, increasing the risk of a false-positive result.
More Related Videos
08:52Psychophysical Tracking Method to Assess Taste Detection Thresholds in Children, Adolescents, and Adults: The Taste Detection Threshold (TDT) Test
Published on: April 21, 2021
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Blind Procedures
Pharmaceutical Poisoning: Potential Scenarios